# Sublingual Glycine vs. Placebo on Attentional Difficulties and Hyperactivity in Prepuberal Children

> **NCT02655276** · NA · COMPLETED · sponsor: **Eberhard Schulz** · enrollment: 30 (actual)

## Conditions studied

- Motor Activity
- Attention Deficit
- Stress, Psychological

## Interventions

- **OTHER:** microencapsulated Glycine
- **OTHER:** Placebo tablets

## Key facts

- **NCT ID:** NCT02655276
- **Lead sponsor:** Eberhard Schulz
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2017-12-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02655276

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02655276, "Sublingual Glycine vs. Placebo on Attentional Difficulties and Hyperactivity in Prepuberal Children". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02655276. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*